THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
106,249,720
Share change
-17,652,878
Total reported value
$40,383,995
Put/Call ratio
72%
Price per share
$0.38
Number of holders
107
Value change
-$6,460,833
Number of buys
34
Number of sells
59

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q1 2022

As of 31 Mar 2022, THERAPEUTICSMD INC - COM (TXMD) was held by 107 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 106,249,720 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, C WorldWide Group Holding A/S, Rubric Capital Management LP, NORTHERN TRUST CORP, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, and RENAISSANCE TECHNOLOGIES LLC. This page lists 107 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.